C-reactive Protein Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Assay Type, By Detection Range, By Disease Area, By End-Use Industry, By Region & Competition, 2020-2030F

Description

Global C-reactive protein (CRP) testing market was valued at USD 1,680.20 million in 2024 and is expected to witness steady growth, with a projected compound annual growth rate (CAGR) of 2.10% through 2030. CRP testing is a widely utilized laboratory diagnostic tool that measures the concentration of C-reactive protein-a liver-produced biomarker indicative of inflammation-in the blood. This test is instrumental in evaluating the body's inflammatory response to infections, injuries, and chronic conditions.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 1680.20 Million
Market Size 2030	USD 1907.91 Million
CAGR 2025-2030	2.10%
Fastest Growing Segment	Immunoturbidimetric Assays
Largest Market	North America

Healthcare professionals frequently use CRP testing to diagnose and monitor a broad range of conditions, including infectious diseases, autoimmune disorders, cardiovascular ailments, and post-surgical complications. Test results, reported in milligrams per liter (mg/L), provide valuable insight into the severity and progression of inflammation, supporting timely diagnosis and disease management strategies.

Key Market Drivers

Increasing Prevalence of Inflammatory and Infectious Diseases

A primary factor fueling market expansion is the growing global burden of inflammatory and infectious diseases. CRP testing is a critical diagnostic and prognostic tool used to detect and monitor a wide spectrum of conditions, including infections, autoimmune diseases, and cardiovascular disorders. As the incidence of these conditions rises globally, the demand for reliable inflammatory biomarkers like CRP continues to grow.

CRP testing is particularly important in managing chronic inflammatory diseases such as rheumatoid arthritis (RA), inflammatory bowel disease (IBD), and lupus, as well as acute conditions like sepsis and pneumonia. It is estimated that 18 million individuals are affected by RA worldwide, with women comprising 70% of cases and over half of the affected population aged 55 or older. Notably, 13 million people suffer from moderate to severe RA, where early diagnosis and rehabilitation can significantly improve quality of life.

The rising prevalence of autoimmune and inflammatory conditions-driven by a combination of genetic, environmental, and lifestyle factors-has prompted broader adoption of CRP testing in routine clinical diagnostics.

Key Market Challenges

Lack of Specificity in Elevated CRP Levels

One of the key challenges limiting the market's full potential is the non-specific nature of elevated CRP levels. While CRP is a reliable marker of inflammation, it does not provide diagnostic specificity regarding the underlying cause. This ambiguity can complicate clinical decision-making, requiring additional tests to identify the root condition, thereby prolonging diagnosis and treatment initiation.

Furthermore, due to its generalized nature, CRP testing is sometimes ordered inappropriately or excessively, particularly in cases where inflammation may not be clinically significant. This can lead to unnecessary healthcare spending and inefficient utilization of resources, contributing to diagnostic overuse and potential overdiagnosis.

Key Market Trends

Growing Emphasis on Personalized Medicine

The increasing focus on personalized medicine represents a transformative trend shaping the CRP testing market. Personalized medicine seeks to tailor medical treatment based on individual patient profiles, including genetic characteristics, lifestyle, and biomarker data. CRP serves as a critical biomarker for inflammation, enabling healthcare providers to design more targeted and effective treatment plans.

CRP testing plays a pivotal role in risk assessment, particularly for cardiovascular diseases, where elevated CRP levels may signal higher risk and prompt preventive interventions tailored to an individual's needs. It also supports continuous disease monitoring, allowing clinicians to track inflammation over time and make informed adjustments to treatment regimens based on changing CRP values.

Key Market Players

Thermo Fisher Scientific, Inc.
F. Hoffmann-La Roche Ltd.
Danaher Corp
Quest Diagnostics
Siemens Healthineers AG
Abbott Laboratories Inc.
Merck KGaAA
Zoetis Inc.
Ortho Clinical Diagnostics
Getein Biotech, Inc.

Report Scope:

In this report, the Global C-reactive Protein Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

C-reactive Protein Testing Market, By Assay Type:

Immunoturbidimetric Assay
ELISA
Chemiluminescence Immunoassay
Others

C-reactive Protein Testing Market, By Detection Range:

hs-CRP
Conventional CRP
cCRP

C-reactive Protein Testing Market, By Disease Area:

Cardiovascular Diseases
Cancer
Rheumatoid Arthritis
Inflammatory Bowel Disease
Endometriosis
Lupus
Others

C-reactive Protein Testing Market, By End-User:

Hospitals & Clinics
Laboratories
Assisted Living Healthcare Facilities
Homecare
Others

C-reactive Protein Testing Market, By region:

North America
- United States
- Canada
- Mexico
Asia-Pacific
- China
- India
- South Korea
- Australia
- Japan
Europe
- Germany
- France
- United Kingdom
- Spain
- Italy
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global C-reactive Protein Testing Market.

Available Customizations:

Global C-reactive Protein Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. C-reactive Protein Testing Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Assay Type (Immunoturbidimetric Assay, ELISA, Chemiluminescence Immunoassay, Others)
- 5.2.2. By Detection Range (hs-CRP, Conventional CRP, cCRP)
- 5.2.3. By Disease Area (Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, Others)
- 5.2.4. By End-Use Industry (Hospitals & Clinics, Laboratories, Assisted Living Healthcare Facilities, Homecare, Others)
- 5.2.5. By Region
- 5.2.6. By Company (2024)
5.3. Market Map

6. North America C-reactive Protein Testing Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Assay Type
- 6.2.2. By Detection Range
- 6.2.3. By Disease Are
- 6.2.4. By End-Use Industry
- 6.2.5. By Country
6.3. North America: Country Analysis
- 6.3.1. United States C-reactive Protein Testing Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Assay Type
    - 6.3.1.2.2. By Detection Range
    - 6.3.1.2.3. By Disease Are
    - 6.3.1.2.4. By End-Use Industry
- 6.3.2. Canada C-reactive Protein Testing Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Assay Type
    - 6.3.2.2.2. By Detection Range
    - 6.3.2.2.3. By Disease Are
    - 6.3.2.2.4. By End-Use Industry
- 6.3.3. Mexico C-reactive Protein Testing Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Assay Type
    - 6.3.3.2.2. By Detection Range
    - 6.3.3.2.3. By Disease Are
    - 6.3.3.2.4. By End-Use Industry

7. Europe C-reactive Protein Testing Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Assay Type
- 7.2.2. By Detection Range
- 7.2.3. By Disease Are
- 7.2.4. By End-Use Industry
- 7.2.5. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany C-reactive Protein Testing Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Assay Type
    - 7.3.1.2.2. By Detection Range
    - 7.3.1.2.3. By Disease Are
    - 7.3.1.2.4. By End-Use Industry
- 7.3.2. United Kingdom C-reactive Protein Testing Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Assay Type
    - 7.3.2.2.2. By Detection Range
    - 7.3.2.2.3. By Disease Are
    - 7.3.2.2.4. By End-Use Industry
- 7.3.3. Italy C-reactive Protein Testing Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Assay Type
    - 7.3.3.2.2. By Detection Range
    - 7.3.3.2.3. By Disease Are
    - 7.3.3.2.4. By End-Use Industry
- 7.3.4. France C-reactive Protein Testing Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Assay Type
    - 7.3.4.2.2. By Detection Range
    - 7.3.4.2.3. By Disease Are
    - 7.3.4.2.4. By End-Use Industry
- 7.3.5. Spain C-reactive Protein Testing Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Assay Type
    - 7.3.5.2.2. By Detection Range
    - 7.3.5.2.3. By Disease Are
    - 7.3.5.2.4. By End-Use Industry

8. Asia-Pacific C-reactive Protein Testing Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Assay Type
- 8.2.2. By Detection Range
- 8.2.3. By Disease Are
- 8.2.4. By End-Use Industry
- 8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China C-reactive Protein Testing Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Assay Type
    - 8.3.1.2.2. By Detection Range
    - 8.3.1.2.3. By Disease Are
    - 8.3.1.2.4. By End-Use Industry
- 8.3.2. India C-reactive Protein Testing Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Assay Type
    - 8.3.2.2.2. By Detection Range
    - 8.3.2.2.3. By Disease Are
    - 8.3.2.2.4. By End-Use Industry
- 8.3.3. Japan C-reactive Protein Testing Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Assay Type
    - 8.3.3.2.2. By Detection Range
    - 8.3.3.2.3. By Disease Are
    - 8.3.3.2.4. By End-Use Industry
- 8.3.4. South Korea C-reactive Protein Testing Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Assay Type
    - 8.3.4.2.2. By Detection Range
    - 8.3.4.2.3. By Disease Are
    - 8.3.4.2.4. By End-Use Industry
- 8.3.5. Australia C-reactive Protein Testing Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Assay Type
    - 8.3.5.2.2. By Detection Range
    - 8.3.5.2.3. By Disease Are
    - 8.3.5.2.4. By End-Use Industry

9. South America C-reactive Protein Testing Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Assay Type
- 9.2.2. By Detection Range
- 9.2.3. By Disease Are
- 9.2.4. By End-Use Industry
- 9.2.5. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil C-reactive Protein Testing Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Assay Type
    - 9.3.1.2.2. By Detection Range
    - 9.3.1.2.3. By Disease Are
    - 9.3.1.2.4. By End-Use Industry
- 9.3.2. Argentina C-reactive Protein Testing Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Assay Type
    - 9.3.2.2.2. By Detection Range
    - 9.3.2.2.3. By Disease Are
    - 9.3.2.2.4. By End-Use Industry
- 9.3.3. Colombia C-reactive Protein Testing Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Assay Type
    - 9.3.3.2.2. By Detection Range
    - 9.3.3.2.3. By Disease Are
    - 9.3.3.2.4. By End-Use Industry

10. Middle East and Africa C-reactive Protein Testing Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Assay Type
- 10.2.2. By Detection Range
- 10.2.3. By Disease Are
- 10.2.4. By End-Use Industry
- 10.2.5. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa C-reactive Protein Testing Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Assay Type
    - 10.3.1.2.2. By Detection Range
    - 10.3.1.2.3. By Disease Are
    - 10.3.1.2.4. By End-Use Industry
- 10.3.2. Saudi Arabia C-reactive Protein Testing Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Assay Type
    - 10.3.2.2.2. By Detection Range
    - 10.3.2.2.3. By Disease Are
    - 10.3.2.2.4. By End-Use Industry
- 10.3.3. UAE C-reactive Protein Testing Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Assay Type
    - 10.3.3.2.2. By Detection Range
    - 10.3.3.2.3. By Disease Are
    - 10.3.3.2.4. By End-Use Industry

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions

13. Global C-reactive Protein Testing Market: SWOT Analysis

14. Competitive Landscape

14.1. Thermo Fisher Scientific, Inc.
- 14.1.1. Business Overview
- 14.1.2. Product & Service Offerings
- 14.1.3. Recent Developments
- 14.1.4. Financials (If Listed)
- 14.1.5. Key Personnel
- 14.1.6. SWOT Analysis
14.2. F. Hoffmann-La Roche Ltd.
14.3. Danaher Corp
14.4. Quest Diagnostics
14.5. Siemens Healthineers AG
14.6. Abbott Laboratories Inc.
14.7. Merck KGaAA
14.8. Zoetis Inc.
14.9. Ortho Clinical Diagnostics
14.10.Getein Biotech, Inc.